These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
242 related items for PubMed ID: 21031133
1. Suppression of transforming growth factor-β effects in rabbit subconjunctival fibroblasts by activin receptor-like kinase 5 inhibitor. Sapitro J, Dunmire JJ, Scott SE, Sutariya V, Geldenhuys WJ, Hewit M, Yue BY, Nakamura H. Mol Vis; 2010 Sep 16; 16():1880-92. PubMed ID: 21031133 [Abstract] [Full Text] [Related]
2. SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism. Xiao YQ, Liu K, Shen JF, Xu GT, Ye W. Invest Ophthalmol Vis Sci; 2009 Apr 16; 50(4):1698-706. PubMed ID: 19098325 [Abstract] [Full Text] [Related]
3. Thermoreversible gel for delivery of activin receptor-like kinase 5 inhibitor SB-505124 for glaucoma filtration surgery. Sutariya V, Miladore N, Geldenhuys W, Bhatia D, Wehrung D, Nakamura H. Pharm Dev Technol; 2013 Apr 16; 18(4):957-62. PubMed ID: 22206499 [Abstract] [Full Text] [Related]
4. Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery. Zhang F, Liu K, Cao M, Qu J, Zhou D, Pan Z, Duan X, Zhou Y. Invest Ophthalmol Vis Sci; 2019 Jun 03; 60(7):2743-2752. PubMed ID: 31247081 [Abstract] [Full Text] [Related]
5. A sequential, multiple-treatment, targeted approach to reduce wound healing and failure of glaucoma filtration surgery in a rabbit model (an American Ophthalmological Society thesis). Sherwood MB. Trans Am Ophthalmol Soc; 2006 Jun 03; 104():478-92. PubMed ID: 17471357 [Abstract] [Full Text] [Related]
6. Expression of connective tissue growth factor after glaucoma filtration surgery in a rabbit model. Esson DW, Neelakantan A, Iyer SA, Blalock TD, Balasubramanian L, Grotendorst GR, Schultz GS, Sherwood MB. Invest Ophthalmol Vis Sci; 2004 Feb 03; 45(2):485-91. PubMed ID: 14744889 [Abstract] [Full Text] [Related]
7. Forkhead domain inhibitory-6 attenuates subconjunctival fibrosis in rabbit model with trabeculectomy. Lan C, Tan J, Tang L, Liu G, Huang L, Luo X, Zhou L, Zhu Y, Liu X, Fan N. Exp Eye Res; 2021 Sep 03; 210():108725. PubMed ID: 34375589 [Abstract] [Full Text] [Related]
8. A p38 MAPK inhibitor improves outcome after glaucoma filtration surgery. Nassar K, Tura A, Lüke J, Lüke M, Grisanti S, Grisanti S. J Glaucoma; 2015 Feb 03; 24(2):165-78. PubMed ID: 25493622 [Abstract] [Full Text] [Related]
9. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts. Mun JH, Kim YM, Kim BS, Kim JH, Kim MB, Ko HC. Wound Repair Regen; 2014 Feb 03; 22(1):125-33. PubMed ID: 24471776 [Abstract] [Full Text] [Related]
10. Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs. Meyer-Ter-Vehn T, Grehn F, Schlunck G. Mol Vis; 2008 Jan 25; 14():136-41. PubMed ID: 18334936 [Abstract] [Full Text] [Related]
11. Novel combination therapy reduces subconjunctival fibrosis after glaucoma filtration surgery in the rabbit model. Swogger J, Conner IP, Happ-Smith C, Kemmerer MC, Julian DR, Davis R, Wells A, Schuman JS, Yates CC. Clin Exp Ophthalmol; 2021 Jan 25; 49(1):60-69. PubMed ID: 33426793 [Abstract] [Full Text] [Related]
12. Filtering bleb area and intraocular pressure following subconjunctival injection of CTGF antibody after glaucoma filtration surgery in rabbits. Wang JM, Hui N, Fan YZ, Xiong L, Sun NX. Int J Ophthalmol; 2011 Jan 25; 4(5):480-3. PubMed ID: 22553706 [Abstract] [Full Text] [Related]
15. RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis. Nakamura H, Siddiqui SS, Shen X, Malik AB, Pulido JS, Kumar NM, Yue BY. Mol Vis; 2004 Oct 04; 10():703-11. PubMed ID: 15475878 [Abstract] [Full Text] [Related]
16. Cationic nano-copolymers mediated IKKβ targeting siRNA to modulate wound healing in a monkey model of glaucoma filtration surgery. Ye H, Qian Y, Lin M, Duan Y, Sun X, Zhuo Y, Ge J. Mol Vis; 2010 Nov 26; 16():2502-10. PubMed ID: 21139997 [Abstract] [Full Text] [Related]
17. Inhibition of transforming growth factor-β via the activin receptor-like kinase-5 inhibitor attenuates pulmonary fibrosis. Koh RY, Lim CL, Uhal BD, Abdullah M, Vidyadaran S, Ho CC, Seow HF. Mol Med Rep; 2015 May 26; 11(5):3808-13. PubMed ID: 25585520 [Abstract] [Full Text] [Related]
18. Pluripotent epigenetic regulator OBP-801 maintains filtering blebs in glaucoma filtration surgery model. Yamamoto Y, Mukai A, Ikushima T, Urata Y, Kinoshita S, Hamuro J, Ueno M, Sotozono C. Sci Rep; 2020 Dec 01; 10(1):20936. PubMed ID: 33262357 [Abstract] [Full Text] [Related]
19. A novel aptamer targeting TGF-β receptor II inhibits transdifferentiation of human tenon's fibroblasts into myofibroblast. Zhu X, Li L, Zou L, Zhu X, Xian G, Li H, Tan Y, Xie L. Invest Ophthalmol Vis Sci; 2012 Oct 05; 53(11):6897-903. PubMed ID: 22899759 [Abstract] [Full Text] [Related]
20. Effects of mammalian target of rapamycin inhibitors on fibrosis after trabeculectomy. Igarashi N, Honjo M, Aihara M. Exp Eye Res; 2021 Feb 05; 203():108421. PubMed ID: 33359326 [Abstract] [Full Text] [Related] Page: [Next] [New Search]